Anti-stromal therapy with imatinib inhibits growth and metastasis of gastric carcinoma in an orthotopic nude mouse model. - Wikidata - awgldk - TriplyDB

Anti-stromal therapy with imatinib inhibits growth and metastasis of gastric carcinoma in an orthotopic nude mouse model.

Anti-stromal therapy with imatinib inhibits growth and metastasis of gastric carcinoma in an orthotopic nude mouse model.

http://www.wikidata.org/entity/Q54384034

about

Cancer-Associated Fibroblasts: Their Characteristics and Their Roles in Tumor Growth Tumor stroma as targets for cancer therapy Platelet-derived growth factor-A and vascular endothelial growth factor-C contribute to the development of pulmonary tumor thrombotic microangiopathy in gastric cancer.Mesenchymal Stem Cells Induce Epithelial to Mesenchymal Transition in Colon Cancer Cells through Direct Cell-to-Cell Contact.Phase I study of imatinib, cisplatin and 5-fluoruracil or capecitabine in advanced esophageal and gastric adenocarcinoma.Identification of stromal differentially expressed proteins in the colon carcinoma by quantitative proteomics.Clinical and biological implications of the tumor microenvironment Gasdermin C Is Upregulated by Inactivation of Transforming Growth Factor β Receptor Type II in the Presence of Mutated Apc, Promoting Colorectal Cancer Proliferation.Stroma-directed molecular targeted therapy in gastric cancer.Multikinase inhibitor regorafenib inhibits the growth and metastasis of colon cancer with abundant stroma.Combining molecular targeted drugs to inhibit both cancer cells and activated stromal cells in gastric cancer.Treatment-induced host-mediated mechanisms reducing the efficacy of antitumor therapies.The emerging roles of exosomes in tumor-stroma interaction.Epigenetic control of the tumor microenvironment.PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas.Stroma-directed imatinib therapy impairs the tumor-promoting effect of bone marrow-derived mesenchymal stem cells in an orthotopic transplantation model of colon cancer.Clinical significance of platelet-derived growth factor receptor-β gene expression in stage II/III gastric cancer with S-1 adjuvant chemotherapy.Combination therapy using molecular-targeted drugs modulates tumor microenvironment and impairs tumor growth in renal cell carcinoma.Involvement of platelet-derived growth factor ligands and receptors in tumorigenesis.Silencing of Discoidin Domain Receptor-1 (DDR1) Concurrently Inhibits Multiple Steps of Metastasis Cascade in Gastric Cancer.Expression of cancer-associated fibroblast markers in advanced colorectal cancer.The evolving relationship of wound healing and tumor stroma

P2860

Q26774159-3B5227C6-B18C-456A-8E31-C866A66E0BAD Q27015980-459CBC67-2B78-4E86-8175-9F9C63B68334 Q33406697-2D6D3245-C820-473D-9167-11B0E3531CE4 Q33595542-C9813FE7-450B-46BF-9E19-311699F51327 Q34507843-BA2991C5-5709-4BB9-BE77-8CE27A886D4A Q34757824-89304F32-12F5-4BBA-ABDC-9805F2F8E4DA Q36101223-C02A0A19-06BC-4FE8-B363-EF4F5DBA6E88 Q36190022-44EB840D-22B2-400A-BECF-8FD8CD0F6A9C Q37148199-C6D209E3-E47C-42DC-A635-76BD3196280C Q37211199-DAD4B6E6-EF03-4304-86B3-80B739100BDB Q37448103-571F217F-729A-4D37-B45E-96605B6944F9 Q38092582-8BED320D-02F4-4B7A-A375-D1EF91B1D4CA Q38778513-A75FBB5B-13E6-4C51-BF67-A8F7A1A2107F Q38971785-790B7F68-8822-4CDC-BE1D-740928F7D32A Q39259618-AE74C3C5-6362-4076-A37D-BCC90E1FBB98 Q39310184-5D787730-9BDA-4DB6-A4F6-782B47DAE7DF Q41966545-931B7B33-F2E9-4952-A99C-719B6C84C9BF Q42373333-7C0D41F4-0596-4EC5-81DE-DE74CC5BEE4B Q47756210-636037D7-1A06-4D02-B694-1244DAFCDB6C Q55097289-6F6E20B7-BC28-448E-AD7F-89B32619C4B5 Q55340110-EA23AB90-FA50-46AB-B80D-12C6E0B9ED7D Q59134962-F728C4C1-00CB-4619-AD58-611373009708

P2860

Anti-stromal therapy with imatinib inhibits growth and metastasis of gastric carcinoma in an orthotopic nude mouse model.

http://www.wikidata.org/entity/Q54384034

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Anti-stromal therapy with imat ...... n orthotopic nude mouse model.

@en

Anti-stromal therapy with imat ...... n orthotopic nude mouse model.

@nl

type

label

Anti-stromal therapy with imat ...... n orthotopic nude mouse model.

@en

Anti-stromal therapy with imat ...... n orthotopic nude mouse model.

@nl

prefLabel

Anti-stromal therapy with imat ...... n orthotopic nude mouse model.

@en

Anti-stromal therapy with imat ...... n orthotopic nude mouse model.

@nl

P1433

Q54384034-2A3043FF-6492-4B04-BF8F-257707B2CD86

P1476

Q54384034-EE7E8054-893F-45C5-882F-40C374E5425D

P2093

Q54384034-20CC8961-C55F-4D6A-896A-34EA788AAE52

Q54384034-24D388CD-22D5-4EAE-9D5B-FC0AD1C06CE3

Q54384034-2AADECDB-8B35-4462-B8AB-3F60628ED34A

Q54384034-3D2FA79A-5986-402F-9FBF-FF10D1736D4F

Q54384034-52CA47D7-D399-49DF-8A44-A06729B24474

Q54384034-5EDF80EC-B58E-45B0-96FB-F7445865D2B6

Q54384034-7DF400D2-C653-46D5-ABE6-36AA47D5407E

Q54384034-84EE1F36-4FB7-4191-8C91-B2BE9433BA15

Q54384034-8E1BCCC0-005E-401B-BD45-5225667C08B6

Q54384034-C4E8423A-8D83-490B-8209-0FB996425F26

P2860

Q54384034-017A5370-FE08-4A3D-8E85-C33D8982E71F

Q54384034-0602A091-DB19-44AC-AF4C-246388B045DA

Q54384034-06C4FF0B-02B5-4DEF-9A18-96781DA27932

Q54384034-0C56F56F-8488-4197-A1A8-27C09C35B332

Q54384034-111BAD3C-85A7-45B2-BC01-C82B23BCA8F4

Q54384034-1CDC3999-A38D-41AB-9294-CE6BB2CD3056

Q54384034-21210085-8A3F-4E26-B39D-C171F3EB7D19

Q54384034-2722255C-877E-4347-B5DB-A87695784AB4

Q54384034-2916E8DF-35F8-4953-8C1C-5705548E499E

Q54384034-32F58849-CED2-4446-AAA0-C49905735BF3

P304

Q54384034-F34E7F5A-9CCE-4CBA-96F3-12F50046488A

P31

Q54384034-74CD2B7E-DDD2-476B-94BE-A82ED08DB98B

P356

Q54384034-EA0F8875-D18B-4278-9128-86EEBB37B5CC

P433

Q54384034-5492752F-32CF-42E4-B0B4-593517C7AF3E

P478

Q54384034-4EC3EA6E-3497-414F-892D-430ED342DD84

P577

Q54384034-6643ACAE-8FF1-4AC3-82D8-B9DAC172849F

P5875

Q54384034-B9BFEF28-1AFD-4B35-AB1A-C3194B53724A

P698

Q54384034-17C39080-B720-4A63-9241-1357371B2500

P356

P1433

International Journal of Cancer

P1476

Anti-stromal therapy with imat ...... n orthotopic nude mouse model.

@en

P2093

Eiji Ohara

http://www.w3.org/2001/XMLSchema#string

Kazuaki Chayama

http://www.w3.org/2001/XMLSchema#string

Kei Shinagawa

http://www.w3.org/2001/XMLSchema#string

Mayu Ohnishi

http://www.w3.org/2001/XMLSchema#string

Michiyo Kodama

http://www.w3.org/2001/XMLSchema#string

Miwako Tanaka

http://www.w3.org/2001/XMLSchema#string

Shinji Tanaka

http://www.w3.org/2001/XMLSchema#string

Tomonori Sumida

http://www.w3.org/2001/XMLSchema#string

Wataru Yasui

http://www.w3.org/2001/XMLSchema#string

Yasuhiko Kitadai

http://www.w3.org/2001/XMLSchema#string

P2860

The Hallmarks of Cancer

Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia

Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors

Cancer-related inflammation

Myofibroblasts and mechano-regulation of connective tissue remodelling

Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting

Friends or foes - bipolar effects of the tumour stroma in cancer

Basement membranes: structure, assembly and role in tumour angiogenesis

Tumour-stroma interaction: cancer-associated fibroblasts as novel targets in anti-cancer therapy?

PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor.

P304

2050-2062

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJC.25812

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

128

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50349386

http://www.w3.org/2001/XMLSchema#string

P698

21387285

http://www.w3.org/2001/XMLSchema#string